Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-29

Clinical Trial Update: Visual Reconstitution Therapy After Optic Neuritis [Phase 2]

View source ↗

Summary

Phase 2 trial update on visual reconstitution therapy for optic neuritis, with conditions including optic neuritis and multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Friedemann Paul | Conditions: Optic Neuritis, Multiple Sclerosis | Phase 2 | Status: COMPLETED